Skip to Content
MedicinaMedicina
  • Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Elsevier.
  • Article
  • Open Access

13 February 2008

Vasopressin for treatment of hemodynamic disorders

,
and
1
Clinic of Intensive Therapy
2
Laboratory of Intensive Therapy and Investigations of Hemodynamics, Institute for Biomedical Research
3
Department of Physiology, Kaunas University of Medicine, Lithuania
*
Author to whom correspondence should be addressed.

Abstract

Vasopressin is a 9-amino acid peptide synthesized by magnocellular neurons of the hypothalamus and released from posterior pituitary gland. The primary physiological role of vasopressin is the maintenance of fluid homeostasis. In this review, the classification of vasopressin receptors, namely V1 vascular, V2 renal, V3 pituitary, oxytocin receptors, and purinergic receptors, and the effects of vasopressin on vascular smooth muscles, the heart, and the kidneys are discussed. Mortality rates of vasodilatory (or distributive), for example septic shock, are high. The use of vasopressin is an alternative therapy for vasodilatory shock with better outcome. Vasopressin is effective in resuscitation of adults after ventricular fibrillation or pulseless tachycardia, when epinephrine is not effective.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.